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Abstract
Background: Nowadays, very few patients with non-variceal upper gastrointestinal bleeding fail endoscopic
hemostasis (refractory NVUGIB). This subset of patients poses a clinical dilemma: should they be operated on or
referred to transcatheter arterial embolization (TAE)?
Objectives: To carry out a systematic review of the literature and to perform a meta-analysis of studies that directly
compare TAE and surgery in patients with refractory NVUGIB.
Materials and methods: We searched PubMed, Ovid MEDLINE, and Embase. A combination of the MeSH terms
“gastrointestinal bleeding”; “gastrointestinal hemorrhage”; “embolization”; “embolization, therapeutic”; and “surgery”
were used ((“gastrointestinal bleeding” or “gastrointestinal hemorrhage”) and (“embolization” or “embolization,
therapeutic”) and “surgery”)). The search was performed in June 2018. Studies were retrieved and relevant studies
were identified after reading the study title and abstract. Bibliographies of the selected studies were also examined.
Statistical analysis was performed using RevMan software. Outcomes considered were all-cause mortality,
rebleeding rate, complication rate, and the need for further intervention.
Results: Eight hundred fifty-six abstracts were found. Only 13 studies were included for a total of 1077 patients
(TAE group 427, surgery group 650). All selected papers were non-randomized studies: ten were single-center and
two were double-center retrospective comparative studies, while only one was a multicenter prospective cohort
study. No comparative randomized clinical trial is reported in the literature.
Mortality. Pooled data (1077 patients) showed a tendency toward improved mortality rates after TAE, but this trend
was not statistically significant (OD = 0.77; 95% CI 0.50, 1.18; P = 0.05; I2 = 43% [random effects]). Significant
heterogeneity was found among the studies.
Rebleeding rate. Pooled data (865 patients, 211 events) showed that the incidence of rebleeding was significantly
higher for patients undergoing TAE (OD = 2.44; 95% CI 1.77, 3.36; P = 0.41; I2 = 4% [fixed effects]).
Complication rate. Pooling of the data (487 patients, 206 events) showed a sharp reduction of complications after
TAE when compared with surgery (OD = 0.45; 95% CI 0.30, 0.47; P = 0.24; I2 = 26% [fixed effects]).
Need for further intervention. Pooled data (698 patients, 165 events) revealed a significant reduction of further
intervention in the surgery group (OD = 2.13; 95% CI 1.21, 3.77; P = 0.02; I2 = 56% [random effects]). A great degree
of heterogeneity was found among the studies.
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Conclusions: The present study shows that TAE is a safe and effective procedure; when compared to surgery,
TAE exhibits a higher rebleeding rate, but this tendency does not affect the clinical outcome as shown by the
comparison of mortality rates (slight drift toward lower mortality for patients undergoing TAE). The present study
suggests that TAE could be a viable option for the first-line therapy of refractory NVUGIB and sets the foundation
for the design of future randomized clinical trials.
Limitations: The retrospective nature of the majority of included studies leads to selection bias. Furthermore, the
decision of whether to proceed with surgery or refer to TAE was made on a case-by-case basis by each attending
surgeon. Thus, external validity is low. Another limitation involves the variability in etiology of the refractory
bleeding. TAE techniques and surgical procedure also differ consistently between different studies. Frame time for
mortality detection differs between the studies. These limitations do not impair the power of the present study that
represents the largest and most recent meta-analysis currently available.
Keywords: Abdominal emergency surgery, Complicated peptic ulcer, Embolization, Meta-analysis
Introduction
Definition, etiology, and epidemiology
Upper gastrointestinal bleeding (UGIB) is defined as bleed-
ing originating proximal to the ligament of Treitz and is
usually divided into two main categories: variceal and
non-variceal. Hematemesis and melena are the commonest
presentations. The most frequent cause of non-variceal
bleeding is complicated peptic ulcer, but multiple etiologies
must be taken into account: benign and malignant tumors,
ischemia, gastritis, arterio-venous malformations (such as
Dieulafoy lesions), Mallory-Weiss tears, trauma, and iatro-
genic causes [1]. Another cause for UGIB is transpapillary
hemorrhage, but this specific subset of cases goes beyond
the aims of the present study.
A recent review on the epidemiology of complicated
peptic ulcer disease [2] found that hemorrhage was by
far the most common complication of peptic disease,
with a reported annual incidence of hemorrhage in the
general population ranging from 19.4 cases per 100,000
individuals to 57.0 cases per 100,000 individuals, with
sample size-weighted average 30-day mortality of 8.6%.
This high incidence of complicated peptic ulcer could be
related to an increase in the use of ASA and NSAIDs
and to the increasing number of elderly people. It is easy
to understand how this complication remains a health-
care problem, with a great overall population health and
financial impact.
Vascular anatomy
Thorough knowledge of the anatomy of the suprameso-
colic area is of utmost importance to understand the
pros and cons of angioembolization, and the likelihood
of successful embolization reflects prior knowledge of
the location of the bleed. A complex network of anasto-
motic arteries provides a rich blood supply to the upper
part of the gastrointestinal tract. This can make success-
ful embolization more challenging; however, it decreases
the incidence of post-embolization ischemia [3].
Anatomic variations in the celiac anatomy, most not-
ably in the origins of the hepatic arteries, occur in at
least 50% of the population. Such variations must always
be considered when evaluating a patient angiographically
for NVUGIB [4].
Historical background
Historically, the first-line therapy for NVUGIB was sur-
gery and a myriad of different surgical approaches are de-
scribed in the literature, some of which are still used
today. However, surgery for bleeding peptic ulcers is asso-
ciated with an 8 to 33% risk of post-operative mortality
[5]. Angiography with percutaneous catheterization as a
diagnostic tool for GI bleeding was first performed by
Baum and colleagues in 1965, identifying hemorrhage as
contrast extravasation in four out of eight patients [6].
After a couple of years, Rosch et al. [7] were the first to
successfully control an acute gastric hemorrhage by embo-
lizing the gastroepiploic artery with an autologous blood
clot. Since then, embolization therapy has gained increas-
ing popularity due to its limited physiological trauma,
especially in high-risk patients unfit for surgery. Further-
more, improvements in catheter technology, the develop-
ment of new materials for embolization therapy, and
wider availability of appropriately skilled interventional ra-
diologists have led to the increased use of angiography
and embolization in the management of UGIB. Nowadays,
angiography permits the visualization of the entire mesen-
teric system, thus allowing the identification of more rare
sites of hemorrhage, such as the biliary tree. Its specificity
approaches 100% [4], while the sensitivity remains around
60% [8, 9]. However, the implementation of a CT-angio-
gram, that has accuracy for active bleeding up to 89% [10],
can help overcome this lack of sensitivity. Nevertheless,
angiography has a specific set of complications that in-
cludes access site thrombosis or hemorrhage, contrast
reactions, injury to target vessels (including dissection
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and distal embolization), and ischemic damage after
embolization.
The introduction of proton pomp inhibitors, as well as
the creation and improvement of effective endoscopic
techniques, greatly changed the approach to non-variceal
UGIB, shifting the therapeutic path from a surgery-first to
a conservative-first approach. Nowadays, patients with
NVUGIB that fail endoscopic hemostasis (refractory
NVUGIB) usually have very big ulcers that are located in
difficult areas and bleed from major vessels. These issues,
in combination with the increase in the number of fragile,
elderly patients, many of which have co-morbidities, pose
a real clinical dilemma: should their NVUGIB be managed
surgically, or be referred to an interventional radiologist
for transcatheter arterial embolization (TAE)?
Objectives and rationale of the research
No clear evidence regarding the role of angioemboliza-
tion for the treatment of refractory NVUGIB is currently
available in the literature. The aim of this study is to
carry out a systematic review of the literature and to
perform a meta-analysis of the studies that directly
compare TAE and surgery in patients with NVUGIB.
The results of the study will provide information that
can assist clinicians to make the correct choice between
angioembolization and surgery when managing patients
with NVUGIB.
Materials and methods
Search methods
We searched PubMed, Ovid MEDLINE, and Embase. To
achieve maximum sensitivity, a combination of the
MeSH terms “gastrointestinal bleeding”; “gastrointestinal
hemorrhage”; “embolization”; “embolization, therapeutic”;
and “surgery” were used ((“gastrointestinal bleeding” or
“gastrointestinal hemorrhage”) and (“embolization” or
“embolization, therapeutic”) and “surgery”). The search
was performed in June 2018. Studies were retrieved and
relevant studies were identified after reading the study title
and abstract. Furthermore, the bibliographies of the se-
lected studies were examined to identify any additional
relevant studies.
Selection criteria
We used the PRISMA (Preferred Reporting Items for
Systematic Reviews and Meta-Analyses) guidelines [11]
to formulate the basis of eligibility criteria using the
PICO (P - Populations/People/Patient/Problem, I -
Intervention(s), C - Comparison, O - Outcome) work-
sheet and search strategy (Table 1).
RCTs, case-control, and cohort studies meeting the
following criteria were included: (1) English language,
(2) considering adult patients’ population with refractory
NVUGIB (defined as failure of endoscopic hemostasis or
rebleeding after successful endoscopic hemostasis), (3) dir-
ect comparison of TAE and surgery, and (4) report of at
least one of the considered outcomes (mortality, rebleeding,
complications, need for further intervention). If multiple
trials or studies were published by the same center, only the
most complete one was included. Studies regarding trans-
papillary bleeding were excluded. Case reports, editorials,
letters, and studies containing duplicate data or data already
published were excluded.
Data collection, assessment of study quality, and risk of
bias
Studies were selected by two authors (A.T., Fa.C), and
disagreements were resolved by collegial discussion. The
full text of the included studies was obtained and
reviewed, to determine the relevance and the quality of
the paper. Risk of bias assessment was performed ac-
cording to the Newcastle–Ottawa Quality Assessment
Scale criteria.
Statistical analysis
Statistical analysis was performed using RevMan soft-
ware (Review Manager version 5.3, Nordic Cochrane
Centre, Copenhagen, Denmark). Odds ratio with a 95%
confidence interval was used to compare outcomes. A
fixed effect model was used in case of low heterogeneity,
while a random effects model was used when significant
heterogeneity was noted. Heterogeneity was assessed
using the Cochrane Q square test (P < 0.1 was consid-
ered an indicator of significant heterogeneity) and the I2
estimates (< 25% moderate, 25–50% moderate, > 50%
high heterogeneity).
Outcomes
The outcomes considered for analysis in the present study
were all-cause mortality with no time limit, rebleeding
rate, complication rate, both procedure-related and not
procedure-related, and need for further intervention.
Rebleeding was defined as bleeding from the same site
Table 1 PICO (Patients, Intervention, Comparison, Outcome)
worksheet
Population Adult patients with refractory NVUGIB (defined as
failure of endoscopic hemostasis or rebleeding after
successful endoscopic hemostasis)
Intervention Transcatheter angioembolization (TAE)
Comparison Direct comparison of TAE and surgery; report of at
list one of the considered outcomes. If multiple
trials or studies were published by the same center,
only the most complete one was included. Studies
regarding transpapillary bleeding were excluded
Outcome All-cause mortality with no time limit; rebleeding or
continued bleeding; complications, both procedure-
related and not procedure-related; need for further
intervention for any reason
Tarasconi et al. World Journal of Emergency Surgery            (2019) 14:3 Page 3 of 13
after a successful index procedure or as a continuing
bleeding, not controlled by index procedure. The need for
further intervention comprehends all procedures per-
formed after the index operation, either for a rebleeding
or for a complication deriving from the index operation.
Results
A total of 856 abstracts were found; the majority of them
were excluded because they were not relevant. Of the
remaining 84 studies, 71 were excluded for the following
reasons: 64 did not compare TAE with surgery, one was
based on a pediatric population, four did not have an
English full-text, one did not provide the raw data for the
statistical analysis [12], and another one did not provide
data for the surgical sub-population [13]. Only 13 studies
were selected [14–26] (Fig. 1, Table 2) for inclusion: all the
selected papers were non-randomized studies, published
between January 2004 and January 2017. Of the selected
studies, 10 were single-center retrospective comparative
studies, two were a double-center retrospective compara-
tive study, and only one was a multicenter prospective
cohort study. Currently, no comparative randomized clin-
ical trial is reported in the literature.
Risk of bias
The risk of bias was assessed using the Newcastle–Ottawa
Quality Assessment Scale: all the included papers are of
poor quality with a high risk of bias (Table 3).
Population
A total of 1077 patients were included in the study, with
427 patients in the TAE group and 650 patients in the
surgery group. Only ten of the included studies reported
the mean age of the patients, and the sample size-
weighted mean age is 72.2 years for the TAE group and
69.6 years for the surgery group (Fig. 2).
Criteria for patient allocation
Only a few studies reported the indication that drove the
choice between TAE and surgery. Nykänen et al. [26] de-
cided on the base of the availability of the interventional
radiologist and on the hemodynamic status, with no
Fig. 1 Literature search—flowchart of literature search and study selection according to the PRISMA statement
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other specifications. According to Griffiths [25], indica-
tions for emergency surgery were uncontrollable bleed-
ing at initial endoscopy, rebleeding following endoscopic
hemostasis, proximal small bowel bleeding, and an un-
stable patient diagnosed with a bleeding duodenal ulcer
on computed tomography angiogram; no indications
were reported for TAE. Jailani and colleagues [23] re-
ferred to surgical treatment for patients with acute,
life-threatening, and ongoing bleeding. Patients were re-
ferred to TAE by Eriksson et al. [15] mainly when skilled
interventional radiology coverage was available and the
patient was a poor surgical candidate. Langner [16]
based his decision on the patients’ surgical risk factors
and the overall clinical situation. Defreyene and col-
leagues [17] did not provide any clear criteria to refer
patients to surgical or angiographic treatment, but they
interestingly found that decision-making after endo-
scopic failure was significantly affected by the presence
of a peptic ulcer. On the other hand, Ripoll and her
group [14] decided on an individual basis whether the
Table 2 Summary of included studies
First author, year
of publication
Country Time frame Etiology of NVUGIB No. of patients Study design
TAE Surgery Total
Ripoll 2004 Spain 1986–2001 Gastric–duodenal ulcers 31 39 70 Single center, retrospective
Eriksson 2008 Sweden (Uppsala) 1998–2005 Various etiologies 40 51 91 Single center, retrospective
Langner 2008 Germany 2001–2006 Various etiologies 11 17 28 Single center, retrospective
Larssen 2008 Norway 2000–2005 Various etiologies 46 51 97 Single center, retrospective
Defreyene 2008 Belgium 1993–2003 Various etiologies 36 10 46 Single center, retrospective
Venclauskas 2010 Lithuania, Sweden 2000–2007 Duodenal ulcers 24 50 74 Double center, retrospective
Wong 2011 Hong Kong 2000–2009 Gastric–duodenal ulcers 32 56 88 Single center, retrospective
Ang 2012 Singapore 2004–2010 Various etiologies 30 63 93 Single center, retrospective
Jairath 2012 UK 2007 Various etiologies 60 97 157 Multicenter, prospective
Jailani 2014 Malaysia 2006–2012 Various etiologies 24 21 45 Single center, retrospective
Laursen 2015 Denmark 1997–2013 Gastric–duodenal ulcers 45 73 118 Single center, retrospective
Griffiths 2016 Australia 2004–2012 Various etiologies 24 79 103 Double center, retrospective
Nykänen 2017 Finland 2000–2015 Gastric–duodenal ulcers 24 43 67 Single center, retrospective
Table 3 Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses — Good quality: 3 or
4 stars (*) in selection domain AND 1 or 2 stars in comparability domain AND 2 or 3 stars in outcome domain; Fair quality: 2 stars in
selection domain AND 1 or 2 stars in comparability domain AND 2 or 3 stars in outcome/exposure domain; Poor quality: 0 or 1 star
in selection domain OR 0 stars in comparability domain OR 0 or 1 stars in outcome/exposure domain
Study Selection Comparability
of cohorts
Outcome Quality/
total
score
Representativeness
of exposed cohort
Selection of
non-exposed
cohort
Ascertainment
of exposure
Outcome not
present at
baseline
assessment
of outcome
Sufficient
follow-up
duration
Adequate
follow-up
Ripoll * * * – – * * – Poor/5
Eriksson * * * – – * * – Poor/5
Langner * * * – * * – – Poor/5
Larssen * * * – – * – – Poor/4
Defreyene * * * – – * * – Poor/5
Venclauskas * * * – – * – – Poor/4
Wong * * * – – * – – Poor/4
Ang * * * – – * * – Poor/5
Jairath * * * – – * * – Poor/5
Jailani * * * – – * – – Poor/4
Laursen * * * – – * – – Poor/4
Griffiths * * * – – * * * Poor/6
Nykänen * * * – – * – – Poor/4
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patient would benefit from emergency laparotomy or
embolization therapy and embolization therapy was con-
sidered when the patient was at high surgical risk. The
remaining papers did not provide any information on
patients’ allocation [18–22].
Etiology of bleeding
Only six studies focused their attention on bleeding de-
riving exclusively from a duodenal or gastric peptic ulcer
[14, 18–20, 24, 26]. The remaining seven studies include
different etiologies that cause NVUGIB (anastomotic
ulcer, Dieulafoy ulcers of the stomach and duodenum,
post-operative pseudo-aneurysm, angiodysplastic lesions,
leiomyomas, post-sphincterectomy bleeding, duodenal
and jejunal diverticuli, etc.).
TAE techniques
Significant differences are present in the techniques and
the materials utilized for angioembolization among the
considered studies. Two studies did not report any data
about TEA procedures [22, 24]. In the other studies, the
types of embolization agents included coils, gel-foam
particles, and polyvinyl alcohol particles. An evident ex-
travasation of contrast into the bowel lumen was consid-
ered as active bleeding. In the absence of a clear contrast
extravasation, prophylactic embolization was performed
on the base of the endoscopic evidence or on the guide
of clips placed during the first endoscopy.
Type of surgery
According to the variability of the etiologies underlying the
bleeding, surgical procedures considered in the selected
studies differ remarkably. Under-running suture of the
ulcer is by far the most commonly performed surgical pro-
cedure, followed by partial and total gastrectomy and trun-
cal vagotomy with pyloroplasty. A variety of other
procedures (ligation of gastroduodenal artery, small bowel
resection, excision of polyp, ulcer excision, etc.) are also
present and constitute a small proportion of the included
cases. None of the included studies specify whether surgery
was performed laparoscopically or with an open approach.
Clinical outcome — Mortality (Fig. 3)
All thirteen studies reported the mortality rate. The def-
inition for mortality included death from all causes and
the time frame varies between studies: 30-day mortality
was used in seven studies [15, 18, 20, 21, 23, 24, 26],
in-hospital mortality was used in four studies [14, 17, 22,
25], and two studies did not report any time frame for
mortality [16, 19]. Pooled data from all the 13 studies
(1077 patients) showed a tendency toward improved mor-
tality rates after TAE, but this trend is not statistically sig-
nificant (OD = 0.77; 95% CI 0.50, 1.18; P = 0.05; I2 = 43%
[random effects]). Furthermore, statistically significant
heterogeneity was found among the studies.
Clinical outcome — Rebleeding rate (Fig. 4a, b)
Eleven out of the 13 selected studies reported a rebleed-
ing rate. Rebleeding was defined as recurrent bleeding or
Fig. 2 Average age — Graphical comparison of the average age of the TAE and surgery groups across included studies
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as continuous bleeding after the primary procedure has
been performed. The time frame for rebleeding is speci-
fied in only three studies (within 1 week from the index
procedure [21]; distinction between rebleeding after 3
days and after 30 days [17], and within 30 days [26]).
Pooled data (865 patients, 211 events) showed that the
incidence of rebleeding was significantly higher for pa-
tients undergoing TAE, compared to those who under-
went surgery (OD = 2.44; 95% CI 1.77, 3.36; P = 0.41;
I2 = 4% [fixed effects]).
Clinical outcome — Complication rate (Fig. 5a, b)
The complication rate was reported in only six studies
and is defined as the number of patients with at least
one complication. The following subsets were included
in the complication rate: TAE-related complications,
surgery-related complications, and medical complica-
tions. Only major complications were included for the
present meta-analysis. Only three studies [15, 20, 26]
analyzed selectively TAE-related (i.e., pancreatitis, acute
kidney injury, duodenal ischemia, and coil misplacement)
and surgery-related complications (i.e., post-operative
abscess, duodenal stump of anastomotic leakage, paralytic
ileus, dehiscence of the fascia). Pooling of the data (487
patients, 206 events) showed a sharp reduction of
complications after TAE compared to surgery (OD = 0.45;
95% CI 0.30, 0.47; P = 0.24; I2 = 26% [fixed effects]). Fur-
thermore, no significant heterogeneity was found among
the studies.
Clinical outcome — Need for further intervention (Fig. 6)
Nine studies analyzed the need for further intervention
after the index procedure. This category includes every
invasive procedure (mainly endoscopy, angioemboliza-
tion, or surgery) needed to secure hemostasis or to treat
a complication. Pooled data (698 patients, 165 events)
revealed a significant reduction of further intervention
in the surgery group (OD = 2.13; 95% CI 1.21, 3.77;
P = 0.02; I2 = 56% [random effects]). A great degree of
heterogeneity was found among the studies, and this
could be related to a selection bias, because some of the
studies did not report the need for additional intervention
in the case of a procedure-related complication, but only
in the case of rebleeding.
Discussion
In the case of non-variceal upper-GI bleeding, when
medical and endoscopic treatment fails, surgery or trans-
catheter embolization is the available treatment option.
Over the past few decades, the number of patients re-
quiring surgical intervention has decreased enormously.
In the 1990s, up to 13% of patients required surgery to
control bleeding from peptic ulcer disease [27], but with
improved endoscopic hemostatic techniques and intra-
venous proton pump inhibitor infusions, the rate of
surgical procedures has dropped to less than 2% in the
present day [28, 29]. In fact, endoscopic treatment is ex-
tremely effective in controlling NVUGIB, but despite ad-
equate initial endoscopic therapy, refractory NVUGIB
can occur in up to 24% of high-risk patients [30] and
mortality after a surgical salvage in the recent UK
National Audit was still as high as 29% [22]. The techno-
logical advances in interventional radiology are improving
rapidly, whilst the experience of surgeons in the manage-
ment of upper GI hemorrhage is declining. This trend is
likely to continue in the future, so it is necessary to pre-
cisely determine the criteria that drive the choice between
surgical and radiological treatment for NVUGIB.
In 1999, a prospective randomized study from Lau et
al. [31] compared endoscopic retreatment with surgery
for rebleeding after initial endoscopy and found that in
patients with peptic ulcers and recurrent bleeding,
Fig. 3 In-hospital all-cause mortality — Comparison of mortality rates rates between the two study groups, forest plot of comparison (random effects)
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endoscopic retreatment reduces the need for surgery
without increasing the risk of death and is associated
with fewer complications than surgery. Furthermore,
identification of the source of recurrent bleeding at a sec-
ond endoscopy can lead to the placement of endoscopic
clips at the ulcer rim; should endoscopic treatment fail
to control the hemorrhage, the metal clips could pro-
vide the interventional radiologist with useful informa-
tion to identify and embolize the culprit vessel in the
absence of angiographic stigmata of bleeding [32]. This
implies that in the case of a bleeding peptic ulcer,
surgical hemostasis or angiographic embolization
should be performed after failure of repeated endos-
copy. The same study from Lau [31] found that
hypotension at randomization (P = 0.01) and an ulcer size
of at least 2 cm (P = 0.03) were independent factors pre-
dictive of the failure of endoscopic retreatment, suggesting
that patients with hypotension and/or ulcer larger than 2
cm may undergo surgery/angiography without repeated
endoscopy. This finding was confirmed by Wong et al. in
2011 in a retrospective review of a cohort of 3271 patients
with peptic ulcer bleeding [20].
A
B
Fig. 4 Rebleeding rates — Comparison of rebleeding rates between the two study groups (fixed effects). a Forest plot of comparison. b Funnel
plot of comparison
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Despite the limitations of the present study, this is the
most updated and comprehensive meta-analysis, to our
knowledge, that compares surgery to angioembolization
for refractory NVUGIB and the results that arise from it
are extremely interesting.
We found no difference in mortality rates between the
two procedures, with a slight drift to a lower mortality
in the TAE group (odds ratio [OD] = 0.77; 95% confi-
dence interval [CI] 0.50, 1.18; P = 0.05; I2 = 43 [random
effects]) (Fig. 4), despite the higher incidence of rebleed-
ing after TAE (OD = 2.44; 95% CI 1.77, 3.36; P = 0.41;
I2 = 4% [fixed effects]) (Fig. 5a, b). A statistically signifi-
cant heterogeneity was found among the studies in mor-
tality rates, and this could be due to the different
time-frames for mortality assessment used between the
different studies (30-day mortality was used in seven
studies [15, 18, 20, 21, 23, 24, 26], in-hospital mortality
was used in four studies [14, 17, 22, 25], and two studies
did not report any time frame for mortality [16, 19]).
These results are even more important given the base-
line differences in the two groups: frailer, older patients
with more comorbidities tended to be treated with TAE.
This undeniable selection bias is related to the methods
for allocation of patients in the two arms of the
meta-analysis: none of the included studies provides a
clear list of the indication for TAE and the decision was
mostly made by the attending surgeon on an individual
basis; on the basis of personal experience, availability of
A
B
Fig. 5 Complication rates — Comparison of complication rates between the two study groups (fixed effects). a Forest plot of comparison.
b Funnel plot of comparison
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an interventional radiologist, and operating room; and
on the basis of patient clinical conditions and com-
orbidities. Defreyene and colleagues [17] found that
decision-making after endoscopic failure was signifi-
cantly affected by the presence of a peptic ulcer: regard-
less of the bleeding severity or their clinical condition,
patients with a peptic ulcer at endoscopy were 5.2 times
more likely to be referred to surgery, and neither indir-
ect parameters of hemodynamic instability nor coagu-
lopathy independently influenced the choice of rescue.
This bias was also reported by Beggs et al. [33] that
found a statistically significant higher incidence of coag-
ulopathy and ischemic heart disease in patients undergo-
ing TAE. On the other hand, a recent systematic review
on embolization for NVUGIB found a mean technical
success rate of 84% and a mean clinical success rate of
67%; while mean rebleeding rate, mean complication
rate, and mean 30-day all-cause mortality were 27, 6,
and 8%, respectively [34]. The same study analyzed the
factors related to angioembolization failure and found
that the presence of coagulopathy and/or multi-organ
failure has the worst impact on the outcome of
embolization. In light of the above statement, the differ-
ences in patients’ comorbidities and coagulopathy at
time of intervention between the two cohorts analyzed
in the present study could then explain the higher rate
of rebleeding in the TAE group. Furthermore, the study
from Defreyne et al [17] showed that rebleeding after
TAE was observed only in the early post-procedural
period (within 3 days), while after that time period,
rebleeding episodes were observed only in the surgery
group. This result further strengthens the hypothesis
that rebleeding rate in the TAE group could be related
to temporary physiological derangements. Another as-
pect that can explain this higher rate of rebleeding is the
intermittent nature of this kind of hemorrhage, that
makes it harder to identify the bleeding site during the
angiographic study and could lead to notable variations
in vessel diameters, thus making the embolic agent too
small to completely occlude the vessel.
The complication rate is unarguably in favor of TAE
(OD = 0.45; 95% CI 0.30, 0.47; P = 0.24; I2 = 26% [fixed
effects]) (Fig. 6a, b), even if only six of the analyzed stud-
ies reported complications. Although the upper GI tract
usually has a rich collateral blood supply, previous stud-
ies have shown ischemic complications to occur in 7 to
16% of cases [35, 36] and they can either present acutely,
with GI necrosis, or later, with ischemic duodenal sten-
osis. It is important to remember that multiple factors,
such as previous surgery, pancreatitis, and radiation
therapy, can interfere with collateral circulation and
cause ischemia. Poultsides et al. [35] reported four (7%)
cases of bowel ischemia following embolization, all of
whom had surgically altered anatomy. Other known
causes of ischemia include the use of embolic agents, such
as liquid agents (e.g., cyanoacrylate glue) or very small
particles (e.g., gelatin sponge powder) that occlude more
distally in the vascular bed. Only three of the included
studies [15, 20, 26] selectively analyzed TAE-related (i.e.,
pancreatitis, contrast-induced nephropathy, duodenal
ischemia, coil misplacement, embolization of non-target
vessels, access site arterial trauma, intimal dissection, or
pseudo-aneurysm formation) and surgery-related compli-
cations (i.e., post-operative abscess, duodenal stump of
anastomotic leakage, paralytic ileus, dehiscence of the
fascia). The most accurate report is from Nykänen et al.
[26] that described, out of 53 embolizations, one (1.8%)
iatrogenic dissection of superior mesenteric artery, four
(7.5%) acute kidney injuries with three of them requiring
dialysis, four (7.5%) gastroduodenal ischemic findings at
follow-up endoscopy, and one (1.8%) migrating coil pro-
truding through the duodenal ulcer into the duodenal
lumen. These numbers are probably the closest to the real
incidence of TAE-related complications; the tendency to-
ward complications under-report in the other studies
could be related to lack of data or difficulties in data
Fig. 6 Need for further intervention — Comparison of reintervention rates between the two study groups. Forest plot of comparison (random effects)
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collection, given the retrospective nature of the studies
and the wide time spread of the analyzed cases (from 1986
to 2015). The increased complication rate after surgical
treatment could also explain the absence of differences in
mortality rate despite the increased risk of rebleeding after
TAE: the choice between TAE and surgery seems to
inevitably pose the dilemma of having an increased risk of
rebleeding or an increased risk of complications.
Consideration of these two possibilities must be weighted
for individual patients and could be the element that
drives treatment strategy, given the absence of strong,
evidence-based recommendations.
In 2001, Defreyne et al. found that clinical parameters
such as surgery after endovascular embolization failure
negatively impacted survival [37]. This result is ex-
tremely interesting and necessitates further investigation
of this specific subset of patients, because it is plausible
that the relative ischemia induced by a previous em-
bolization could negatively affect the results of surgery.
If this were the case, a meticulous evaluation of the
rebleeding risk could be necessary and surgery as a first
option could be taken into account for patients with a
high rebleeding risk.
A recent retrospective study from the Karolinska Insti-
tute [12], not included in this study because it did not
provide raw data for the meta-analysis, included 282 pa-
tients with a 3-year follow-up, found a significant reduc-
tion in mortality and hospital length of stay after TAE,
that could be explained by the comparability in terms of
age and comorbidities of patients in the surgery and
TAE groups. This is a further stimulus to implement
TAE into everyday management of refractory NVUGIB.
The discussion of the results for the last analyzed out-
come, i.e., the need for further intervention after the
index operation, is limited by the nature of the included
studies. In fact, only nine of them included this outcome
in their analysis but a great degree of heterogeneity was
found and this could be related to a selection bias, be-
cause some of the studies did not report the need for
additional intervention in the case of procedure-related
complications, but only in the case of rebleeding.
Nevertheless, our meta-analysis revealed a significant re-
duction of further intervention in the surgery group
(OD = 2.13; 95% CI 1.21, 3.77; P = 0.02; I2 = 56%
[random effects]) (Fig. 6), but this result is likely to be
related to the increased rate of rebleeding found in the
TAE group.
Some confusion still remains on the applications of TAE
in hemodynamically unstable patients, and none of the in-
cluded studies analyzed this specific subset of patients.
From the existing data, it seems that physician expertise
and availability of equipment are the driving factors in the
decision to perform TAE on hemodynamically unstable
patients. More specifically, it is likely possible to perform
TAE in these patients in facilities with a 24-h availability
of an expert interventional radiologist and a hybrid OR,
while it is not recommended in smaller facilities with lim-
ited resources.
It is also necessary to take into account the previous
surgical history of the patient, because it could signifi-
cantly alter the vascular anatomy, and the presence of
post-surgical adhesions could make access to the gastro-
duodenal area arduous and time-consuming.
Limitations
The study has some limitations. First of all, the retro-
spective nature of the majority of included studies leads
to an inevitable selection bias. Furthermore, the decision
between TAE and surgery was made on an individual
case-by-case basis by the attending surgeon, making
group allocation and randomization difficult to achieve.
This may lead to low external validity. Furthermore, al-
though the most common cause of refractory bleeding is
a peptic ulcer, there remain a variety of etiologies. TAE
and surgical techniques also vary among the included
studies. Regarding complications, only a few studies re-
ported a complication rate for the analyzed procedures
and some studies reported reintervention rates only in
case of rebleeding after the index procedure; thus, the
analysis of the reintervention and complication rates
may not represent everyday reality. Lastly, the modality
of mortality detection differs between the studies
(in-hospital mortality, 30-day mortality, overall mortality,
etc.). These limitations do not impair the power of the
present study that represents the largest and most recent
meta-analysis available.
Conclusions
The management of NVUGIB refractory to endoscopic
treatment remains a clinical dilemma and the decision
between TAE and surgery is usually made on an individ-
ual basis by the attending surgeon. The aim of this
meta-analysis is to gather the currently available evi-
dence, thus providing a guide for every clinician facing
this emergency. Unfortunately, the quality of the studies
currently published is low and their retrospective nature
increases the likelihood of selection bias.
Nevertheless, the results of the present study show
that TAE is a safe and an effective procedure and, when
compared to surgery, TAE has a higher rebleeding rate,
but this tendency does not affect the clinical outcome.
In fact, the comparison of mortality rates for the two
procedures highlights a slight drift toward a lower mor-
tality for patients undergoing TAE, despite the fact that
the TAE patient population usually includes those with
greater comorbidities unfit for surgery.
The present study suggests that TAE could be a viable
option as a first-line therapy for refractory NVUGIB
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and, in the absence of evidence of superiority of one spe-
cific approach, local factors, such as organization of
surgical and radiological services, availability of specific
radiological skills, services availability during night shift
and weekends, etc., will continue to determine the thera-
peutic pathway. This study also aims to set the basis for
the design of future randomized clinical trials. Another
issue to be addressed in the future is the best treatment
option for refractory NVUGIB in hemodynamically un-
stable patients.
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